查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1715363

按疾病、产品类型和最终用户分類的眼科市场—2025-2030 年全球预测

Ophthalmology Market by Diseases, Product Type, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2023 年眼科市场价值将达到 597.8 亿美元，2024 年将成长至 637.2 亿美元，复合年增长率为 6.62%，到 2030 年将达到 936.9 亿美元。

主要市场统计数据
基准年2023年 597.8亿美元
预计2024年 637.2亿美元
预测年份 2030 936.9亿美元
复合年增长率（%） 6.62%

近年来，在科技的快速进步、患者需求的变化和不断创新的推动下，眼科领域经历了蓬勃发展。眼科产业的转型特点是致力于改善患者的治疗效果，同时解决一系列与眼睛相关的疾病。这种不断发展的模式反映了严谨的研究、对技术的大量投资以及改进临床实践的迭代过程。随着传统方法与新诊断工具和治疗通讯协定的交叉，该领域正在看到数位健康解决方案的整合不断增加，从而提高了效率并改善了病人参与。

革命性的手术设备和数位影像技术的引入带来了模式转移，不仅提高了诊断的准确性，而且增强了治疗性介入的有效性。这些进步以持续的研究和对新兴市场需求的深入了解为基础。医疗保健专业人员、研究人员和技术公司共同努力，为P2P学习和创新创造了肥沃的环境，为患者照护树立了新的标准。本执行摘要为深入分析奠定了基础，揭示了推动眼保健未来发展轨蹟的最重要的变革力量和细分动力。

正在重新定义眼科领域的变革

眼科市场正在经历深刻的变化，重新定义临床和商业策略。这一变化的前沿是先进诊断和治疗技术的整合，这些技术重塑了患者接受护理的方式。行业相关人员正在见证数位解决方案与传统治疗方法的融合，以提高诊断和手术程序的准确性和效率。这些变革性转变不仅限于技术创新，还包括推动个人化医疗采用的不断发展的法律规范和报销格局。

远端医疗作为远距离诊断和病患监测的可行、可扩展的解决方案的出现反映了以患者为中心的护理的更广泛转变。随着临床医生接受资料分析和人工智慧，该领域的临床决策能力将会得到改善，这反过来将有助于提高治疗成功率。同样，扩增实境和机器人辅助手术正在透过缩短恢復时间和减少併发症为精准医疗开闢新的途径。

此外，全球对综合医疗保健体系的呼吁正在刺激各个研究机构、医疗保健提供者和科技公司之间的合作努力。随着传统治疗模式日益受到创新方法的挑战，眼科学界将受益于更便利、更有效率、更有效的眼部疾病整体治疗方法。

更深入的细分洞见推动市场动态

眼科市场的复杂性最好透过其多方面的细分来理解。从具体疾病来看，包括老龄化黄斑部病变、白内障、青光眼、发炎性疾病、屈光不良等多种疾病。每种疾病不仅需要量身定制的治疗计划，而且还代表着标靶治疗方法的进展指标。

根据产品类型，市场涵盖药品、设备、处方眼镜和镜片以及软体解决方案。在医药领域，药品进一步分为治疗过敏性结膜炎和发炎的药物、治疗干眼症的药物、治疗青光眼的药物和治疗视网膜疾病的药物等。设备是另一个重要类别，分为诊断设备和手术设备。手术器械本身包括人工水晶体和眼科雷射等子区隔，它们在现代外科手术中至关重要。这种细緻的市场区隔使得产业参与者能够不断改进其技术和临床方法，以满足特定的市场需求。

根据最终用户评估市场可以揭示进一步的策略见解。医疗服务供应商以及医院、医疗中心和研究机构在提供眼科护理方面都发挥着至关重要的作用。这种细分凸显了患者需求、医疗保健基础设施和创新治疗之间的错综复杂关係，从而为该领域的有针对性的投资和研究主导的进步提供了清晰的道路。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 眼科疾病盛行率和大众意识不断提高
      • 处方眼镜和隐形眼镜的普及率不断提高
      • 拥有完善的医疗基础设施和不断增加的药品核准数量
    • 限制因素
      • 眼部护理费用高昂
    • 机会
      • 眼保健的新研究活动和津贴可用性
      • 眼科技术整合保证高可用性
    • 任务
      • 熟练的眼科医生数量有限
  • 市场区隔分析
    • 疾病：相当一部分人口患有近视、远视、散光、老花等屈光不正
    • 产品类型：加大眼科软体开发投入
    • 最终用户：世界各地医疗机构正在进行的研究活动
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 眼科市场（按疾病）

  • 老龄化黄斑部病变
  • 白内障
  • 青光眼
  • 发炎性疾病
  • 屈光不正

第七章眼科市场（依产品类型）

  • 药物
    • 过敏性结膜炎和发炎药物
    • 干眼症药物
    • 青光眼药物
    • 视网膜疾病治疗
  • 装置
    • 诊断设备
    • 手术设备
      • 人工水晶体
      • 眼科雷射
  • 处方笺眼镜和镜片
  • 软体

第 8 章眼科市场（按最终用户划分）

  • 医疗保健服务供应商
  • 医院
  • 医疗机构
  • 研究组织

第九章美洲眼科市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太眼科市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 11 章欧洲、中东和非洲的眼科市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023年市场占有率分析
  • 2023年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • AbbVie Inc.
  • Alcon Inc.
  • Alkeus Pharmaceuticals, Inc.
  • Apotex Inc.
  • Bausch Health Companies Inc.
  • CH Boehringer Sohn AG & Co. KG
  • Carl Zeiss AG
  • ClearSight LLC
  • Duopharma Biotech Berhad
  • Essex Bio-Technology Limited
  • EssilorLuxottica SA
  • Eyenovia, Inc.
  • F. Hoffmann-La Roche AG
  • GenSight Biologics SA
  • Geri-Care Pharmaceuticals Corp.
  • Glaukos Corporation
  • Halma PLC
  • Harrow Health, Inc.
  • Honeywell International Inc.
  • Hoya Corporation
  • Johnson & Johnson Services Inc.
  • Kubota Pharmaceutical Holdings Co., Ltd.
  • Lumenis Be Ltd. by Boston Scientific
  • Nidek Co., Ltd.
  • Novartis AG
  • OCuSOFT, Inc.
  • Oxurion NV
  • Pfizer, Inc.
  • Reichert by Ametek Inc.
  • Santen Pharmaceutical Co., Ltd.
  • SEED Co., Ltd.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • The Cooper Companies, Inc.
  • Topcon Corporation
  • Unimed Pharma, Spols ro
  • Visioncare Optolab Pvt. Ltd.
  • Ziemer Group
Product Code: MRR-4348D129FA96

The Ophthalmology Market was valued at USD 59.78 billion in 2023 and is projected to grow to USD 63.72 billion in 2024, with a CAGR of 6.62%, reaching USD 93.69 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 59.78 billion
Estimated Year [2024] USD 63.72 billion
Forecast Year [2030] USD 93.69 billion
CAGR (%) 6.62%

In recent years the ophthalmology sector has experienced dynamic growth fueled by rapid technological advancements, evolving patient needs, and continuous innovation. The industry's transformation is marked by a commitment to enhancing patient outcomes while addressing a diverse range of eye-related conditions. This evolving landscape reflects rigorous research, substantial investments in technology, and an iterative process of improving clinical practices. As traditional methodologies intersect with novel diagnostic tools and treatment protocols, the sector also sees broader integration of digital health solutions, leading to increased efficiency and improved patient engagement.

The introduction of breakthrough surgical equipment and digital imaging techniques has brought about a paradigm shift that not only increases the accuracy of diagnostics but also amplifies the effectiveness of therapeutic interventions. Such advancements are supported by ongoing research and a deep understanding of emerging market needs. The collaboration among healthcare professionals, researchers, and technology firms has enabled a fertile environment for peer-to-peer learning and innovation, setting new standards in patient care. This executive summary sets the stage for an in-depth analysis that unpacks the transformative forces and segmentation dynamics which are paramount in driving the future trajectory of ophthalmology.

Transformative Shifts Redefining the Ophthalmology Landscape

The ophthalmology market is undergoing significant shifts that are redefining both clinical and commercial strategies. At the forefront of these changes is the integration of advanced diagnostic and therapeutic technologies that have reoriented how patients receive care. Industry stakeholders are witnessing a convergence between digital solutions and traditional treatment modalities, resulting in improved accuracy and efficiency in diagnosis as well as in surgical procedures. These transformative shifts extend beyond technological innovation; they touch upon evolving regulatory frameworks and reimbursement landscapes that encourage the adoption of personalized care.

The emergence of telemedicine as a viable and scalable solution for remote diagnosis and patient monitoring reflects a broader shift towards patient-centric care. As clinicians embrace data analytics and artificial intelligence, the field sees improved clinical decision-making which in turn promotes higher treatment success rates. Similarly, augmented reality and robotic-assisted surgeries are pioneering new pathways in precision medicine by reducing recovery times and minimizing complications.

Furthermore, the global call for integrated healthcare systems is driving collaborative efforts across various research institutes, healthcare providers, and technology companies. As traditional treatment paradigms are increasingly challenged by innovative methods, the industry is set to benefit from a more accessible, efficient, and effective approach to managing a wide range of ophthalmic conditions.

Deep Dive into Segmentation Insights Driving Market Dynamics

The complexity of the ophthalmology market is best understood through its multifaceted segmentation, which offers a clear picture of the diverse factors influencing its growth. When examined by disease, the market encompasses a range of conditions including Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders. Each condition not only demands tailor-made treatment plans but also serves as a benchmark for advancements in targeted therapeutic approaches.

Looking at the product type, the market expands into drugs, equipment, prescription glasses and lenses, and software solutions. Within the realm of pharmaceuticals, drugs are further categorized into segments such as Allergic Conjunctivitis and Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. Equipment is another critical category that bifurcates into diagnostic devices and surgical devices. Surgical devices themselves constitute a sub-segment including intraocular lenses and ophthalmic lasers which are pivotal in modern surgical interventions. This nuanced breakdown enables industry players to address specific market needs while continually refining their technological and clinical approaches.

Evaluating the market based on end user reveals further strategic insights. Service providers that deliver healthcare along with hospitals, medical institutes, and research organizations each play a vital role in the delivery of eye care. This segmentation underscores the intricate interplay between patient needs, medical infrastructure, and innovative treatments, thereby setting a clear path for targeted investments and research-driven advancements in the field.

Based on Diseases, market is studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders.

Based on Product Type, market is studied across Drugs, Equipment, Prescription Glasses & Lens, and Software. The Drugs is further studied across Allergic Conjunctivitis & Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. The Equipment is further studied across Diagnostic Devices and Surgical Devices. The Surgical Devices is further studied across Intraocular Lenses and Ophthalmic Lasers.

Based on End User, market is studied across Healthcare Service Providers, Hospitals, Medical Institutes, and Research Organizations.

Regional Insights Shaping Global Ophthalmology Trends

Regional analysis provides crucial visibility into the broad spectrum of growth opportunities and healthcare challenges that shape the ophthalmology market globally. In the Americas, advanced healthcare infrastructure combined with a high level of technological adoption has fostered a robust environment for clinical research and market expansion. Market dynamics in this region are heavily characterized by a strong emphasis on patient-centric innovations and the rapid adoption of digital diagnostic tools.

Across Europe, the Middle East, and Africa, there exists a diverse mix of market maturity levels. Innovative healthcare policies, combined with significant investments in research and development, propel performance improvements and enhanced patient care. Regulatory frameworks in these regions are designed to support both emerging and established players, thereby nurturing an environment of healthy competition and breakthrough innovations.

In the Asia-Pacific region, the growing economies and increasing healthcare awareness have resulted in a surge in demand for sophisticated healthcare services and state of the art diagnostic equipment. Rapid urbanization, coupled with an expanding population, drives the need for scalable and efficient ophthalmic solutions. The interplay of these factors not only broadens market participation but also fuels the development of cost-effective treatment modalities that can be seamlessly integrated into both rural and metropolitan healthcare systems.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Insights Driving Competitive Advantage

Competitive leadership in the ophthalmology market is predominantly steered by companies that have consistently demonstrated innovation and strategic foresight. Leading industry players include AbbVie Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Apotex Inc., Bausch Health Companies Inc., C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, ClearSight LLC, Duopharma Biotech Berhad, Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., F. Hoffmann-La Roche AG, GenSight Biologics S.A., Geri-Care Pharmaceuticals Corp., Glaukos Corporation, Halma PLC, Harrow Health, Inc., Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services Inc., Kubota Pharmaceutical Holdings Co., Ltd., Lumenis Be Ltd. by Boston Scientific, Nidek Co., Ltd., Novartis AG, OCuSOFT, Inc., Oxurion NV, Pfizer, Inc., Reichert by Ametek Inc., Santen Pharmaceutical Co., Ltd., SEED Co., Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., The Cooper Companies, Inc., Topcon Corporation, Unimed Pharma, Spols r.o., Visioncare Optolab Pvt. Ltd., and Ziemer Group.

These organizations have carved out distinct market positions by investing heavily in research and development and forging strategic alliances that extend their operational capacities both in the domestic and international arenas. Their innovative product portfolios, supported by continuous advancements in technology and impeccable clinical performance records, contribute to heightened industry standards. The synergy between research excellence and commercial strategy has resulted in improved treatment outcomes and a reinforced commitment to patient-centric approaches, thereby driving sustainable market growth.

The report delves into recent significant developments in the Ophthalmology Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Apotex Inc., Bausch Health Companies Inc., C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, ClearSight LLC, Duopharma Biotech Berhad, Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., F. Hoffmann-La Roche AG, GenSight Biologics S.A., Geri-Care Pharmaceuticals Corp., Glaukos Corporation, Halma PLC, Harrow Health, Inc., Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services Inc., Kubota Pharmaceutical Holdings Co., Ltd., Lumenis Be Ltd. by Boston Scientific, Nidek Co., Ltd., Novartis AG, OCuSOFT, Inc., Oxurion NV, Pfizer, Inc., Reichert by Ametek Inc., Santen Pharmaceutical Co., Ltd., SEED Co., Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., The Cooper Companies, Inc., Topcon Corporation, Unimed Pharma, Spols r.o., Visioncare Optolab Pvt. Ltd., and Ziemer Group. Strategic Recommendations for Industry Leaders

Industry leaders are advised to harness current market trends by focusing on investments in research and development while fostering collaborations that bridge clinical expertise with technological innovation. Embracing digital transformation is essential for improving diagnostic precision and enhancing treatment protocols. A shift towards integrating data analytics and artificial intelligence into clinical decision-making processes can convert raw clinical data into actionable insights, ultimately refining patient care.

Moreover, it is crucial for organizations to actively pursue strategic partnerships with both emerging technology firms and established research institutions. Such collaborative ventures facilitate the exchange of knowledge and promote creations of multi-faceted solutions that address complex ophthalmic conditions. Market leaders should also consider diversifying their product portfolios to include a broader range of drugs and equipment that cater to both high-end and cost-effective treatment options.

Taking proactive steps to monitor evolving regulatory landscapes and patient demographics can further enable leaders to adapt quickly to market changes. Emphasizing sustainable practices while ensuring clinical excellence will not only enhance brand reputation but also ensure long-term viability in an increasingly competitive landscape. By aligning innovation with operational efficiency, industry players stand well-positioned to capitalize on the emerging trends in the ophthalmology market.

Conclusion: Charting the Future for Ophthalmology

The evolving landscape of ophthalmology exemplifies a delicate balance between technological innovation, strategic partnerships, and patient-focused initiatives. Through a detailed examination of market segmentation, regional dynamics, and competitive forces, the findings highlight a clear trajectory pointing towards enhanced diagnostic precision, integrated treatment modalities, and robust patient care. Industry advances in digital health, coupled with sustained investments in research and development, are driving the transformation of care across diverse regions and patient segments.

The convergence of innovative products and clinical excellence is setting new benchmarks in the industry. By capitalizing on technological breakthroughs and tailoring solutions to specific patient needs, stakeholders remain at the forefront of driving change. To realize the full potential of these transformative trends, a collaborative approach that unites clinical expertise with commercial acumen is imperative. This summary encapsulates the fundamental factors propelling the sector forward and reinforces the commitment to achieving higher standards of patient care and business growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of eye disorders and growing awareness among the population
      • 5.1.1.2. Increasing adoption of prescription glasses and lenses
      • 5.1.1.3. Presence of well-equipped healthcare infrastructure and an increasing number of drug approvals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of ophthalmologic treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging research activities of ophthalmology treatments and availability of grants
      • 5.1.3.2. High usage potential owing to the technological integrations in Ophthalmology
    • 5.1.4. Challenges
      • 5.1.4.1. Limited skilled professionals for ophthalmic procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Diseases: Prevalence of refractive errors such as myopia, hyperopia, astigmatism, and presbyopia in a significant portion of the population
    • 5.2.2. Product Type: Increasing investments in software development in ophthalmology
    • 5.2.3. End User: Continuous research activities by medical institutes worldwide
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ophthalmology Market, by Diseases

  • 6.1. Introduction
  • 6.2. Age-Related Macular Degeneration
  • 6.3. Cataract
  • 6.4. Glaucoma
  • 6.5. Inflammatory Diseases
  • 6.6. Refractive Disorders

7. Ophthalmology Market, by Product Type

  • 7.1. Introduction
  • 7.2. Drugs
    • 7.2.1. Allergic Conjunctivitis & Inflammation Drugs
    • 7.2.2. Dry Eye Drugs
    • 7.2.3. Glaucoma Drugs
    • 7.2.4. Retinal Disorder Drugs
  • 7.3. Equipment
    • 7.3.1. Diagnostic Devices
    • 7.3.2. Surgical Devices
      • 7.3.2.1. Intraocular Lenses
      • 7.3.2.2. Ophthalmic Lasers
  • 7.4. Prescription Glasses & Lens
  • 7.5. Software

8. Ophthalmology Market, by End User

  • 8.1. Introduction
  • 8.2. Healthcare Service Providers
  • 8.3. Hospitals
  • 8.4. Medical Institutes
  • 8.5. Research Organizations

9. Americas Ophthalmology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Ophthalmology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Eyenovia and Formosa Pharmaceuticals collaborate to co-develop clobetasol suspension for dry eye disease relief leveraging Optejet technology
    • 12.3.2. Beacon Therapeutics secures USD 170 Million in series B funding to propel ophthalmic gene therapies and drive global expansion
    • 12.3.3. Thea Pharma Inc. introduced new resources to support latanoprost ophthalmic solution patients
    • 12.3.4. BioPhta raises EUR 6.5 million to propel innovative eye disease treatments to clinical trials and expand global reach
    • 12.3.5. Merck's strategic acquisition of EyeBio aims to advance groundbreaking therapies for retinal diseases
    • 12.3.6. Clario and EmSere forge strategic partnership to revolutionize ophthalmic clinical trials with advanced imaging and data integration
    • 12.3.7. Biocon Biologics Limited received U.S. FDA approval for biosimilar aflibercept, enters U.S. ophthalmology market
    • 12.3.8. Topcon and Microsoft join forces to revolutionize ophthalmic diagnostics with AI-powered healthcare platform
    • 12.3.9. A collaboration between Eye2Gene Limited and Heidelberg Engineering, Inc. was announced at ARVO 2024
    • 12.3.10. Nordic Pharma, Inc. gears up for LACRIFILL launch at ASCRS annual meeting
    • 12.3.11. Carl Zeiss Meditec AG strengthens ophthalmology market position with strategic D.O.R.C. acquisition
    • 12.3.12. Viatris leads innovation with the launch of RYZUMVI(TM) 0.75% to revolutionize eye dilation management
    • 12.3.13. Clario and Cleveland Clinic Foundation's Cole Eye Institute formed a strategic partnership for enhanced ophthalmology clinical trials
    • 12.3.14. Roche's Vabysmo launch in India aims to revolutionize retinal disease treatment with affordability and accessibility
    • 12.3.15. Refocus Eye Health is partnering with eight premier practices in New Jersey to enhance specialized eye services
    • 12.3.16. Ikerian AG unveiled a discovery core platform for enhanced ophthalmic data analysis
    • 12.3.17. Cipla joins forces with CSIR-CDRI to innovate ophthalmic antifungal treatments, accelerating R&D and global market reach
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Alcon Inc.
    • 12.4.2. EssilorLuxottica S.A.
    • 12.4.3. AbbVie Inc.
    • 12.4.4. Bausch Health Companies Inc.

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Alcon Inc.
  • 3. Alkeus Pharmaceuticals, Inc.
  • 4. Apotex Inc.
  • 5. Bausch Health Companies Inc.
  • 6. C.H. Boehringer Sohn AG & Co. KG
  • 7. Carl Zeiss AG
  • 8. ClearSight LLC
  • 9. Duopharma Biotech Berhad
  • 10. Essex Bio-Technology Limited
  • 11. EssilorLuxottica S.A.
  • 12. Eyenovia, Inc.
  • 13. F. Hoffmann-La Roche AG
  • 14. GenSight Biologics S.A.
  • 15. Geri-Care Pharmaceuticals Corp.
  • 16. Glaukos Corporation
  • 17. Halma PLC
  • 18. Harrow Health, Inc.
  • 19. Honeywell International Inc.
  • 20. Hoya Corporation
  • 21. Johnson & Johnson Services Inc.
  • 22. Kubota Pharmaceutical Holdings Co., Ltd.
  • 23. Lumenis Be Ltd. by Boston Scientific
  • 24. Nidek Co., Ltd.
  • 25. Novartis AG
  • 26. OCuSOFT, Inc.
  • 27. Oxurion NV
  • 28. Pfizer, Inc.
  • 29. Reichert by Ametek Inc.
  • 30. Santen Pharmaceutical Co., Ltd.
  • 31. SEED Co., Ltd.
  • 32. Sun Pharmaceutical Industries Limited
  • 33. Teva Pharmaceutical Industries Ltd.
  • 34. The Cooper Companies, Inc.
  • 35. Topcon Corporation
  • 36. Unimed Pharma, Spols r.o.
  • 37. Visioncare Optolab Pvt. Ltd.
  • 38. Ziemer Group

LIST OF FIGURES

  • FIGURE 1. OPHTHALMOLOGY MARKET MULTI-CURRENCY
  • FIGURE 2. OPHTHALMOLOGY MARKET MULTI-LANGUAGE
  • FIGURE 3. OPHTHALMOLOGY MARKET RESEARCH PROCESS
  • FIGURE 4. OPHTHALMOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OPHTHALMOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OPHTHALMOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023